Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value | RobinsPost News & Noticias

Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know


Boston Scientific (BSX) ended the recent trading session at $106.66, demonstrating a +1.1% change from the preceding day's closing price. This move outpaced the S&P 500's daily loss of 0.69%. Read More

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors


In the latest close session, Boston Scientific (BSX) was down 2.65% at $105.23. This move lagged the S&P 500's daily gain of 0.3%. Elsewhere, the Dow saw a downswing of 0.48%, while the tech-heavy ... Read More

Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)


Across the recent three months, 12 analysts have shared their insights on Boston Scientific (NYSE: BSX), expressing a variety of opinions spanning from bullish to bearish. The following table provides ... Read More

Boston Scientific lifts annual profit forecast on strong demand for heart devices


Oct 22 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong demand for its heart devices, sending ... Read More

Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost


Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More

Boston Scientific boosts chronic pain therapy portfolio with Nalu deal


Oct 17 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus